Impact of cytomegalovirus and grafts versus host disease on the dynamics of CD57+CD28-CD8+ T cells after bone marrow transplant

Clinics

Volumn 63, Issue 5, 2008, Pages 667-676

  Mendes, Ana Verena Almeida ^a   Kallas, Esper Georges ^a   Benard, Gil ^a   Pannuti, Cláudio Sérgio ^a   Menezes, Reneé ^a   Dulley, Frederico Luiz ^a   Evans, Thomas George ^a   Salomão, Reinaldo ^a   Machado, Clarisse Martins ^a  

^a NONE

Author keywords

Bone marrow transplant; CD57+ lymphocytes; Cytomegalovirus; Graft versus host disease; Immuno constitution

Indexed keywords

EID: 54349127398     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322008000500016     Document Type: Article

References (49)

1. Sullivan KM. Intravenous immune globulin prophylaxis in recipients of a marrow transplant. J Allergy Clin Immunol. 2003;84:632-8.
2. Goodrich JM, Mori M, Gleaves CA, Du Mond C, Cays M, Ebeling DF, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med. 1991;325:1601-7.
3. Hunter AE., Haynes AP and Russell NH. Bone marrow transplantation: current situation, complications and prevention. J Antimicrob Chemother. 1995;36 (Suppl B): S119-33.
4. Machado CM, Dulley FL, Boas LS, Castelli JB, Macedo MC, Silva RL, et al. CMV pneumonia in allogeneic BMT recipients undergoing early treatment of pre-emptive ganciclovir therapy. Bone Marrow Transplant. 2000;26:413-7.
5. Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G. and Bowden RA. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood. 1996;88:4063-71.
6. Aubert G, Hassan-Walker AF, Madrigal JA, Emery VC, Morte C, Grace, et al. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J Infect Dis. 2001;184:955-63.
7. Bilgrami S, Aslanzadeh J, Feingold JM, Bona RD, Clive J, Dorsky D, et al. Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance. Bone Marrow Transplant. 1999;24:69-73.
8. Mendes AV, Benard G, Pereira CB, Kallas EG, Duarte AJ, Pannuti CS, et al. Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-gamma production in allogeneic and autologous bone marrow transplantation. Acta Haematol. 2002;107:187-94.
9. De Rosa SC, Herzenberg LA and Roederer M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med. 2001;7:245-8.
10. Appay V, Dunbar, PR, Callan M, Klenerman P, Gillespie GM, Papagno L, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8:379-85.
11. Wang EC. and Borysiewicz LK. The role of CD8+, CD57+ cells in human cytomegalovirus and other viral infections. Scand J Infect Dis.1995; (Suppl 99): S69-77.
12. Morley JK, Batliwalla FM, Hingorani R and Gregersen PK. Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset. J Immunol.1995,154: 6182-90.
13. Lieberman J, Trimble LA, Friedman RS, Lisziewicz J, Lori F, Shankar P. and Jessen H. Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection. Aids.1999; 13: 891-9.
14. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711-20.
15. Arai K, Yamamura S, Seki S, Hanyu T, Takahashi HE and Abo T. Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti- inflammatory role. Clin Exp Immunol.1998;111:345-52.
16. Frassanito MA, Silvestris F, Cafforio P and Dammacco. F CD8+/CD57 cells and apoptosis suppress T-cell functions in multiple myeloma. Br J Haematol.1998; 100:469-77.
17. Sze DM, Giesajtis G, Brown RD, Raitakari M, Gibson J, Ho J, et al. Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood. 2001;98:2817-27.
18. Merino J, Martinez-Gonzalez MA, Rubio M, Inoges S, Sanchez-Ibarrola A and Subira ML. Progressive decrease of CD8high+ CD28+ CD57-cells with ageing. Clin Exp Immunol.1998;112:48-51.
19. Gorochov G, Debre P, Leblond V, Sadat-Sowti B, Sigaux F. and Autran B. Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood; 1994;83:587-95.
20. Wang EC, Moss PA, Frodsham P, Lehner PJ, Bell JI. and Borysiewicz LK. CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol. 1995;155:5046-56.
21. Moss P. and Khan N. CD8 (+) T-cell immunity to cytomegalovirus. Hum Immunol. 2004;65:456-64.
22. Evans TG, Kallas EG, Luque AE, Menegus M, McNair C. and Looney RJ. Expansion of the CD57 subset of CD8 T cells in HIV-1 infection is related to CMV serostatus. Aids. 1999;13:1139-41.
23. Looney RJ, Falsey A, Campbell D, Torres A, Kolassa J, Brower C, et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol. 1999; 90: 213-9.
24. Hooper M, Kallas EG, Coffin D, Campbell D, Evans TG and Looney RJ. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J Rheumatol.1999; 26: 1452-7.
25. Ozdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ et al. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood. 2002;100:3690-7.
26. Bronke C, Westerlaken GH, Miedema F, Tesselaar K, and van Baarle D. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells. Immunol Lett. 2005;97:215-24.
27. van der Bij W, Torensma R, van Son WJ, Anema J, Schirm J, Tegzess AM, et al. The TH. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol. 1988;25:179-88.
28. Pannuti CS, Kallas EG, Muccioli C, Roland RK, Ferreira EC, Bueno SM, et al. Cytomegalovirus antigenemia in acquired immunodeficiency syndrome patients with untreated cytomegalovirus retinitis. Am J Ophthalmol. 1996;122:847-52.
29. Ljungman P, Griffiths P. and Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002;34:1094-7.
30. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE, et al. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975;292:895-902.
31. Labalette M, Salez F, Pruvot FR, Noel C and Dessaint JP. CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells. Clin Exp Immunol. 1994;95:465-71.
32. Hazzan M, Labalette M, Noel C, Lelievre G. and Dessaint JP. Recall response to cytomegalovirus in allograft recipients: mobilization of CD57+, CD28+ cells before expansion of CD57+, CD28- cells within the CD8+ T lymphocyte compartment. Transplantation. 1997;63:693-8.
33. d'Angeac AD, Monier S, Pilling D, Travaglio-Encinoza A, Reme T. and Salmon M. CD57+ T lymphocytes are derived from CD57- precursors by differentiation occurring in late immune responses. Eur J Immunol. 1994;24:1503-11.
34. Kern F, Khatamzas E, Surel I, Frommel C, Reinke P, Waldrop SL, et al. Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol.1999;29: 2908-15.
35. Legendre CM, Guttmann RD, Hou SK and Jean R. Two-color immunofluorescence and flow cytometry analysis of lymphocytes in long-term renal allotransplant recipients: identification of a major Leu-7+/Leu-3+ subpopulation. J Immunol.1985;135:1061-6.
36. Yabe H, Yabe M, Kato S, Kimura M and Iwaki K. Increased numbers of CD8+CD11+, CD8+CD11- and CD8+Leu7+ cells in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1990;5:295-300.
37. Horiuchi T, Hirokawa M, Kawabata Y, Kitabayashi A, Matsutani T, Yoshioka T, et al. Identification of the T cell clones expanding within both CD8(+)CD28(+) and CD8(+)CD28(-) T cell subsets in recipients of allogeneic hematopoietic cell grafts and its implication in post-transplant skewing of T cell receptor repertoire. Bone Marrow Transplant. 2001;27:731-9.
38. Bandres E, Merino J, Vazquez B, Inoges S, Moreno C, Subira ML, et al. The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28(-)CD57(+) subpopulation. Clin Immunol. 2000;96:230-5.
39. Weekes MP, Wills MR, Mynard K, Hicks R, Sissons JG. and Carmichael AJ. Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population. Immunology. 1999;98:443-9.
40. Khan N, Cobbold M, Keenan R and Moss PA. Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J Infect Dis. 2002;185:1025-34.
41. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002;169:1984-92.
42. Koike Y, Seki S, Ohkawa T, Kaneko T, Kogawa K, Fujitsuka S, et al. CD57+ T cells augment IFN-gamma production in a one-way mixed lymphocyte reaction and their expansion after stem cell transplantation in pediatric patients. Clin Exp Immunol. 2002;130:162-8.
43. Rowbottom AW, Garland RJ, Lepper MW, Kaneria SS, Goulden NJ, Oakhill A, et al. Functional analysis of the CD8+CD57+ cell population in normal healthy individuals and matched unrelated T-cell-depleted bone marrow transplant recipients. Br J Haematol. 2000;110:315-21.
44. Gillespie GM, Wills MR, Appay V, O'Callaghan C, Murphy M, Smith N, et al. Functional heterogeneity and high frequencies of cytomegalovirusspecific CD8(+) T lymphocytes in healthy seropositive donors. J Virol. 2000;74:8140-50.
45. Dolstra H, Preijers F, Van de Wiel-van Kemenade, E Schattenberg, A Galama J, et al. Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection. Br J Haematol.1995;90:300-7.
46. Dolstra H, Van de Wiel-van Kemenade E, De Witte T and Preijers F. Clonal predominance of cytomegalovirus-specific CD8+ cytotoxic T lymphocytes in bone marrow recipients. Bone Marrow Transplant. 1996;18,339-45.
47. Yu, XZ, Bidwell SJ, Martin PJ. and Anasetti C. CD28-specific antibody prevents graft-versus-host disease in mice. J Immunol. 2000;164:4564-8.
48. Lee S, Chong SY, Lee JW, Kim SC, Min YH, Hahn JS. and Ko YW. Difference in the expression of Fas/Fas-ligand and the lymphocyte subset reconstitution according to the occurrence of acute GVHD. Bone Marrow Transplant. 1997; 20:883-8.
49. Garin L, Rigal D, Souillet G, Nemoz C, Bernaud J, Merieux Y, et al. Allogenic BMT in children: differential lymphocyte subset reconstitution according to the occurrence of acute GVHD. Clin Immunol Immunopathol. 1995;77:139-48.